ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 741

Increased Risk of Recurrent Gout Attacks During Hospitalization

Yuqing Zhang1, Clara Chen2, Hyon K. Choi3, Christine E. Chaisson2, David J. Hunter4 and Tuhina Neogi5, 1Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 2Boston University School of Public Health, Boston, MA, 3Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 4Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 5Clinical Epidemiology, Boston Univ Schl of Med, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research I: Epidemiology and Outcomes in Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: While anecdotal evidence suggests that risk of recurrent gout attack increases during hospitalization and gout is one of the most common reasons for in-patient rheumatology consultations, to our knowledge no study has formally tested this hypothesis.  Understanding the magnitude of risk conferred by hospitalization on recurrent gout attacks would provide clinical guidance as to whether prophylactic therapy should be provided to prevent gout attacks in patients with existing gout during hospitalization, particularly since such attacks contribute to increased length of hospital stay.    

Methods: We conducted an online case-crossover study to assess putative risk factors, including hospitalization, for recurrent gout attacks among persons with pre-existing gout. Those who had experienced at least one gout attack within the previous year were recruited online and underwent verification of gout diagnosis through medical records review.  Participants logged onto the study website when they experienced a gout attack and provided exposure information (including hospitalization) over the two-day period prior to an acute gout attack (case period) using an online questionnaire. The same questionnaire was collected for a two-day period during an intercritical period (control period) in a 3-month interval for up to four times.  We examined the relation of hospitalization and reasons for hospitalization over a 2-day period to the risk of recurrent gout attacks using conditional logistic regression. 

Results: Our analysis included 724 subjects who experienced recurrent gout attacks during the study period (mean age 54.5, mean BMI 32.1, 78.5% male). Over the one-year follow-up period, 35 hospitalizations occurred. Of these, 3 hospitalizations were due to gout-related conditions and were excluded from the analysis. Of the remaining, 10 were for surgery, 9 for acute infections, and 13 for other conditions. The proportion of hospitalization was 5.2 and 15.4 per 1000 person-periods during the control and case periods, respectively.  Adjusting for alcohol consumption, purine intake, and use of diuretics, allopurinol, colchicine, and NSAIDs, the odds of recurrent gout attacks during hospitalization increased by more than 3-fold (odds ratio=3.86, 95% confidence interval: 1.69-8.84) compared with periods without hospitalization (Table).

Conclusion: Our study confirmed that the risk of gout attacks increases during hospitalization. These data support the consideration of the provision of appropriate prophylaxis to patients with pre-existing gout during hospitalization.

 Table.  Hospitalization and Risk of Recurrent Gout Attacks 

     Hospitalization     Over 2 Days

 No. Control   Periods

No. Hazard  Periods

      Adjusted OR        (95% CI)

No

1931

1402

1.00 (referent)

Yes

10

22

3.86 (1.69-8.84)


Disclosure:

Y. Zhang,
None;

C. Chen,
None;

H. K. Choi,
None;

C. E. Chaisson,
None;

D. J. Hunter,
None;

T. Neogi,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-recurrent-gout-attacks-during-hospitalization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology